Evaluation of Antimicrobial Drug Use and Concurrent Infections During Hospitalization of Patients With COVID-19 in Japan

This cross-sectional study examines the prevalence and necessity of antimicrobial drug use among patients who are hospitalized with COVID-19 infection in Japan.

Detalles Bibliográficos
Autores principales: Komagamine, Junpei, Yabuki, Taku, Matsumoto, Kohei, Tanaka, Nao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8857682/
https://www.ncbi.nlm.nih.gov/pubmed/35179589
http://dx.doi.org/10.1001/jamanetworkopen.2022.0040
_version_ 1784654090512367616
author Komagamine, Junpei
Yabuki, Taku
Matsumoto, Kohei
Tanaka, Nao
author_facet Komagamine, Junpei
Yabuki, Taku
Matsumoto, Kohei
Tanaka, Nao
author_sort Komagamine, Junpei
collection PubMed
description This cross-sectional study examines the prevalence and necessity of antimicrobial drug use among patients who are hospitalized with COVID-19 infection in Japan.
format Online
Article
Text
id pubmed-8857682
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Medical Association
record_format MEDLINE/PubMed
spelling pubmed-88576822022-03-03 Evaluation of Antimicrobial Drug Use and Concurrent Infections During Hospitalization of Patients With COVID-19 in Japan Komagamine, Junpei Yabuki, Taku Matsumoto, Kohei Tanaka, Nao JAMA Netw Open Research Letter This cross-sectional study examines the prevalence and necessity of antimicrobial drug use among patients who are hospitalized with COVID-19 infection in Japan. American Medical Association 2022-02-18 /pmc/articles/PMC8857682/ /pubmed/35179589 http://dx.doi.org/10.1001/jamanetworkopen.2022.0040 Text en Copyright 2022 Komagamine J et al. JAMA Network Open. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the CC-BY License.
spellingShingle Research Letter
Komagamine, Junpei
Yabuki, Taku
Matsumoto, Kohei
Tanaka, Nao
Evaluation of Antimicrobial Drug Use and Concurrent Infections During Hospitalization of Patients With COVID-19 in Japan
title Evaluation of Antimicrobial Drug Use and Concurrent Infections During Hospitalization of Patients With COVID-19 in Japan
title_full Evaluation of Antimicrobial Drug Use and Concurrent Infections During Hospitalization of Patients With COVID-19 in Japan
title_fullStr Evaluation of Antimicrobial Drug Use and Concurrent Infections During Hospitalization of Patients With COVID-19 in Japan
title_full_unstemmed Evaluation of Antimicrobial Drug Use and Concurrent Infections During Hospitalization of Patients With COVID-19 in Japan
title_short Evaluation of Antimicrobial Drug Use and Concurrent Infections During Hospitalization of Patients With COVID-19 in Japan
title_sort evaluation of antimicrobial drug use and concurrent infections during hospitalization of patients with covid-19 in japan
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8857682/
https://www.ncbi.nlm.nih.gov/pubmed/35179589
http://dx.doi.org/10.1001/jamanetworkopen.2022.0040
work_keys_str_mv AT komagaminejunpei evaluationofantimicrobialdruguseandconcurrentinfectionsduringhospitalizationofpatientswithcovid19injapan
AT yabukitaku evaluationofantimicrobialdruguseandconcurrentinfectionsduringhospitalizationofpatientswithcovid19injapan
AT matsumotokohei evaluationofantimicrobialdruguseandconcurrentinfectionsduringhospitalizationofpatientswithcovid19injapan
AT tanakanao evaluationofantimicrobialdruguseandconcurrentinfectionsduringhospitalizationofpatientswithcovid19injapan

Ejemplares similares